Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2013-09-09 | Forward | 2:1 |
| 2004-06-16 | Forward | 3:2 |
| 1997-10-21 | Forward | 5:3 |
DaVita Inc. provides kidney dialysis, laboratory, and comprehensive kidney care services across outpatient, hospital, and home settings for over 243,000 patients in the U.S. and internationally.

DaVita is a leading provider of kidney dialysis services, specializing in in-center, peritoneal, and home dialysis, with a focus on an Integrated Kidney Care model for comprehensive chronic kidney disease management.
| Icon | PRODUCT | Q3-2024 | Q4-2024 | Q1-2025 | Q4-2025 |
|---|---|---|---|---|---|
![]() | U S Dialysis And Related Lab Services | $2.91B | $5.66B ▲ | $1.61B ▼ | $10.12B ▲ |
| Map | REGION | Q1-2014 | Q2-2014 | Q3-2014 |
|---|---|---|---|---|
![]() | U S | $206.96M | $222.72M ▲ | $240.77M ▲ |
![]() | International | $23.25M | $24.04M ▲ | — |
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
RVMD | $207.88 | COMPARE |
BMRN | $64.67 | COMPARE |
ALGN | $157.58 | COMPARE |
MOH | $200.00 | COMPARE |
BIO | $387.70 | COMPARE |
UHS | $171.66 | COMPARE |
HSIC | $89.52 | COMPARE |
ENSG | $172.98 | COMPARE |